Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1989 Apr;33(4):503–507. doi: 10.1128/aac.33.4.503

Do double-beta-lactam combinations prolong neutropenia in patients undergoing chemotherapy or bone marrow transplantation for hematological disease?

C C Kibbler 1, H G Prentice 1, R J Sage 1, A V Hoffbrand 1, M K Brenner 1, P Noone 1
PMCID: PMC172468  PMID: 2658793

Abstract

The total period of neutropenia was assessed in 174 episodes after chemotherapy or bone marrow transplantation in which patients received antibiotics for fever in a randomized prospective trial. Log rank analysis demonstrated no significant difference in the total duration of neutropenia between patients receiving netilmicin plus either piperacillin or azlocillin and those given ceftazidime plus either piperacillin or azlocillin. Of 86 patients in the single-beta-lactam group, 27 had a persistent neutrophil count of 0.1 x 10(9) per liter during treatment compared with 27 of 88 patients in the double-beta-lactam group, and 29 of 68 patients treated with the single-beta-lactam combination had a total period of neutropenia greater than 30 days versus 36 of 75 in the double-beta-lactam group. The use of two beta-lactam antibiotics rather than one does not appear to prolong neutropenia in patients undergoing treatment of hematological malignancy. However, in order to determine the effect of a single-beta-lactam combination, a similar carefully controlled prospective randomized study in which such treatment is compared with a non-beta-lactam-containing regimen is required.

Full text

PDF
503

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bodey G. P., Buckley M., Sathe Y. S., Freireich E. J. Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med. 1966 Feb;64(2):328–340. doi: 10.7326/0003-4819-64-2-328. [DOI] [PubMed] [Google Scholar]
  2. Murphy M. F., Riordan T., Minchinton R. M., Chapman J. F., Amess J. A., Shaw E. J., Waters A. H. Demonstration of an immune-mediated mechanism of penicillin-induced neutropenia and thrombocytopenia. Br J Haematol. 1983 Sep;55(1):155–160. doi: 10.1111/j.1365-2141.1983.tb01233.x. [DOI] [PubMed] [Google Scholar]
  3. Neftel K. A., Hauser S. P., Müller M. R. Inhibition of granulopoiesis in vivo and in vitro by beta-lactam antibiotics. J Infect Dis. 1985 Jul;152(1):90–98. doi: 10.1093/infdis/152.1.90. [DOI] [PubMed] [Google Scholar]
  4. Neftel K. A., Hübscher U. Effects of beta-lactam antibiotics on proliferating eucaryotic cells. Antimicrob Agents Chemother. 1987 Nov;31(11):1657–1661. doi: 10.1128/aac.31.11.1657. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Rouveix B., Lassoued K., Vittecoq D., Regnier B. Neutropenia due to beta lactamine antibodies. Br Med J (Clin Res Ed) 1983 Dec 17;287(6408):1832–1834. doi: 10.1136/bmj.287.6408.1832. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Schimpff S. C., Greene W. H., Young V. M., Wiernik P. H. Significance of Pseudomonas aeruginosa in the patient with leukemia or lymphoma. J Infect Dis. 1974 Nov;130 (Suppl)(0):S24–S31. doi: 10.1093/infdis/130.supplement.s24. [DOI] [PubMed] [Google Scholar]
  7. Winston D. J., Barnes R. C., Ho W. G., Young L. S., Champlin R. E., Gale R. P. Moxalactam plus piperacillin versus moxalactam plus amikacin in febrile granulocytopenic patients. Am J Med. 1984 Sep;77(3):442–450. doi: 10.1016/0002-9343(84)90100-1. [DOI] [PubMed] [Google Scholar]
  8. Young L. S. Double beta-lactam therapy in the immunocompromised host. J Antimicrob Chemother. 1985 Jul;16(1):4–6. doi: 10.1093/jac/16.1.4. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES